ATE524559T1 - Methode zur verbesserung der proteinproduktion - Google Patents

Methode zur verbesserung der proteinproduktion

Info

Publication number
ATE524559T1
ATE524559T1 AT03779044T AT03779044T ATE524559T1 AT E524559 T1 ATE524559 T1 AT E524559T1 AT 03779044 T AT03779044 T AT 03779044T AT 03779044 T AT03779044 T AT 03779044T AT E524559 T1 ATE524559 T1 AT E524559T1
Authority
AT
Austria
Prior art keywords
protein
sequence
cell
trap
protein expression
Prior art date
Application number
AT03779044T
Other languages
English (en)
Inventor
Arie Otte
Blokland Henricus Van
Original Assignee
Chromagenics Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chromagenics Bv filed Critical Chromagenics Bv
Application granted granted Critical
Publication of ATE524559T1 publication Critical patent/ATE524559T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression

Landscapes

  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT03779044T 2002-12-18 2003-12-02 Methode zur verbesserung der proteinproduktion ATE524559T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02080347 2002-12-18
PCT/NL2003/000850 WO2004055215A1 (en) 2002-12-18 2003-12-02 A method for improving protein production

Publications (1)

Publication Number Publication Date
ATE524559T1 true ATE524559T1 (de) 2011-09-15

Family

ID=32524041

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03779044T ATE524559T1 (de) 2002-12-18 2003-12-02 Methode zur verbesserung der proteinproduktion

Country Status (9)

Country Link
US (2) US7413896B2 (de)
EP (1) EP1573058B1 (de)
AT (1) ATE524559T1 (de)
AU (1) AU2003285823B2 (de)
CA (1) CA2510179C (de)
DK (1) DK1573058T3 (de)
ES (1) ES2373549T3 (de)
NZ (1) NZ540471A (de)
WO (1) WO2004055215A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2344070T3 (es) 2001-07-04 2010-08-17 Chromagenics B.V. Secuencias de adn con actividad anti-represora.
AU2003243059A1 (en) 2002-06-14 2003-12-31 Chromagenics B.V. Use of repression blocking sequences in methods for enhancing gene expression
NZ537073A (en) 2002-06-14 2006-08-31 Chromagenics B A method for simultaneous production of multiple proteins; vectors and cells for use therein
ES2373549T3 (es) 2002-12-18 2012-02-06 Chromagenics B.V. Método para mejorar la producción de proteínas.
AU2003290453A1 (en) 2002-12-20 2004-07-14 Chromagenics B.V. Means and methods for producing a protein through chromatin openers that are capable of rendering chromatin more accessible to transcription factors
US20100136616A1 (en) * 2004-11-08 2010-06-03 Chromagenics B.V. Selection of Host Cells Expressing Protein at High Levels
US8999667B2 (en) 2004-11-08 2015-04-07 Chromagenics B.V. Selection of host cells expressing protein at high levels
US20060195935A1 (en) * 2004-11-08 2006-08-31 Chromagenics B.V. Selection of host cells expressing protein at high levels
US8039230B2 (en) 2004-11-08 2011-10-18 Chromagenics B.V. Selection of host cells expressing protein at high levels
AU2005300503B2 (en) 2004-11-08 2010-12-16 Chromagenics B.V. Selection of host cells expressing protein at high levels
US20060172382A1 (en) * 2004-11-08 2006-08-03 Chromagenics B.V. Selection of host cells expressing protein at high levels
US7566655B2 (en) * 2005-05-26 2009-07-28 Applied Materials, Inc. Integration process for fabricating stressed transistor structure
US7732342B2 (en) * 2005-05-26 2010-06-08 Applied Materials, Inc. Method to increase the compressive stress of PECVD silicon nitride films
BRPI0613784A2 (pt) * 2005-07-21 2011-02-01 Abbott Lab expressão de gene múltipla incluindo constructos sorf e métodos com poliproteìnas, pro-proteìnas e proteólise
US20080293086A1 (en) * 2006-09-18 2008-11-27 Cobalt Technologies, Inc. A Delaware Corporation Real time monitoring of microbial enzymatic pathways
US20090081715A1 (en) * 2007-09-07 2009-03-26 Cobalt Technologies, Inc., A Delaware Corporation Engineered Light-Emitting Reporter Genes
EP2268825A4 (de) 2008-04-09 2012-05-02 Cobalt Technologies Inc Immobilisierte produkttolerante mikroorganismen
AU2010266035B2 (en) * 2009-06-26 2015-02-12 Talfryn S.A. Integrated system and process for bioproduct production
EP2493923A1 (de) * 2009-10-30 2012-09-05 Abbott Laboratories Sorf-konstrukte und multiple genexpression
SG11201510748PA (en) * 2013-08-21 2016-03-30 Curevac Ag Composition and vaccine for treating lung cancer

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5610053A (en) 1993-04-07 1997-03-11 The United States Of America As Represented By The Department Of Health And Human Services DNA sequence which acts as a chromatin insulator element to protect expressed genes from cis-acting regulatory sequences in mammalian cells
US5733782A (en) * 1993-10-25 1998-03-31 Creative Biomolecules, Inc. Methods and compositions for high protein production from non-native DNA
US5972605A (en) 1994-07-07 1999-10-26 Geron Corporation Assays for regulators of mammalian telomerase expression
US5773695A (en) 1996-01-26 1998-06-30 North Carolina State University Plant nuclear scaffold attachment region and method for increasing gene expression in transgenic cells
US5888809A (en) 1997-05-01 1999-03-30 Icos Corporation Hamster EF-1α transcriptional regulatory DNA
JP4220673B2 (ja) 1998-07-21 2009-02-04 ミリポア・コーポレイション 遍在性クロマチンオープニングエレメント（ｕｃｏｅ）を含むポリヌクレオチド
EP1104490B8 (de) 1998-08-14 2008-02-13 Chromagenics B.V. Dns sequenz, verfahren für dessen nachweis und herstellung und ihre benutzung
US6521419B1 (en) 1998-09-22 2003-02-18 Kanakaraju Koduri Expression vectors containing hot spot for increased recombinant protein expression in transfected cells
US6800457B2 (en) 1998-09-22 2004-10-05 Bristol-Myers Squibb Company Expression vectors containing hot spot for increased recombinant protein expression in transfected cells
US6395549B1 (en) 1998-10-22 2002-05-28 Medical College Of Georgia Research Institute, Inc. Long terminal repeat, enhancer, and insulator sequences for use in recombinant vectors
US6586205B1 (en) 2000-02-11 2003-07-01 Millennium Pharmaceuticals, Inc. 43239 a novel GPCR-like molecule and uses thereof
US20030166042A1 (en) 2000-02-11 2003-09-04 Millennium Pharmaceuticals, Inc. Novel seven-transmembrane proteins/G-protein coupled receptors
AU9006701A (en) 2000-09-20 2002-04-02 Cobra Therapeutics Ltd Polynucleotide
US6787321B1 (en) * 2000-10-13 2004-09-07 The Regents Of The University Of California Mammalian two-hybrid system for screening for modulators of the accumulation of metabolic products
IL152423A0 (en) 2001-02-23 2003-05-29 Novartis Ag Novel vector constructs
ES2344070T3 (es) 2001-07-04 2010-08-17 Chromagenics B.V. Secuencias de adn con actividad anti-represora.
EP1273666A1 (de) 2001-07-04 2003-01-08 Chromagenics B.V. Verfahren zur Selektion einer transkription-modulatierenden DNA-Sequenz unter Verwendung einem Vektor mit einem transkriptions-repressions-aktivem Element
ITMI20012110A1 (it) * 2001-10-12 2003-04-12 Keryos Spa Vettori multi-cistronici utilizzabili in protocolli di trsferimento genico
NZ537073A (en) 2002-06-14 2006-08-31 Chromagenics B A method for simultaneous production of multiple proteins; vectors and cells for use therein
ES2373549T3 (es) 2002-12-18 2012-02-06 Chromagenics B.V. Método para mejorar la producción de proteínas.
AU2003290453A1 (en) 2002-12-20 2004-07-14 Chromagenics B.V. Means and methods for producing a protein through chromatin openers that are capable of rendering chromatin more accessible to transcription factors
US20100136616A1 (en) 2004-11-08 2010-06-03 Chromagenics B.V. Selection of Host Cells Expressing Protein at High Levels
US8999667B2 (en) 2004-11-08 2015-04-07 Chromagenics B.V. Selection of host cells expressing protein at high levels
US20060172382A1 (en) 2004-11-08 2006-08-03 Chromagenics B.V. Selection of host cells expressing protein at high levels
AU2005300503B2 (en) 2004-11-08 2010-12-16 Chromagenics B.V. Selection of host cells expressing protein at high levels
US8039230B2 (en) 2004-11-08 2011-10-18 Chromagenics B.V. Selection of host cells expressing protein at high levels
US20060195935A1 (en) 2004-11-08 2006-08-31 Chromagenics B.V. Selection of host cells expressing protein at high levels
US7968700B2 (en) 2006-03-20 2011-06-28 Chromagenics B.V. Expression augmenting DNA fragments, use thereof, and methods for finding thereof

Also Published As

Publication number Publication date
AU2003285823A1 (en) 2004-07-09
US20060010506A1 (en) 2006-01-12
AU2003285823B2 (en) 2008-06-19
US8173422B2 (en) 2012-05-08
US20090011468A1 (en) 2009-01-08
NZ540471A (en) 2008-07-31
EP1573058A1 (de) 2005-09-14
EP1573058B1 (de) 2011-09-14
ES2373549T3 (es) 2012-02-06
US7413896B2 (en) 2008-08-19
CA2510179C (en) 2013-04-23
DK1573058T3 (da) 2012-01-16
WO2004055215A1 (en) 2004-07-01
CA2510179A1 (en) 2004-07-01

Similar Documents

Publication Publication Date Title
ATE524559T1 (de) Methode zur verbesserung der proteinproduktion
DE602004020321D1 (de) Endomannosidasen zur modifzierung der glykoproteine in eukaryoten
FR2822164B1 (fr) Polypeptides derives des arn polymerases, et leurs utilisations
SG143066A1 (en) Dna sequences comprising gene transcription regulatory qualities and methods for detecting and using such dna sequences
DE60335195D1 (de) Mutante e. coli-appa-phytaseenzyme und natürliche varianten davon, solche phytaseenzyme codierende nukleinsäuren, diese enthaltende vektoren und wirtszellen und verfahren zur herstellung und verwendung davon
ATE374828T1 (de) Expressionsvektor zur antibiotikafreien expression
ATE469223T1 (de) Pilz transkriptionsaktivator zur verwendung in verfahren zur herstellung von polypeptiden
SG156672A1 (en) Methods for refolding of recombinant antibodies
ATE543506T1 (de) Methode zur stabilisierung von proteinen
ATE355382T1 (de) Verfahren zur fermentativen herstellung von l- threonine
ATE465241T1 (de) Verfahren zur fermentativen herstellung von proteinen
DE60228847D1 (de)
TW200510450A (en) Soluble fragments of the SARS-CoV spike glycoprotein
ATE516341T1 (de) Verfahren zur fermentativen herstellung von heterologen proteinen mittels escherichia coli
ATE492631T1 (de) Verwendung von mutationen zur verbesserung von aspergillus-phytasen
DE60219632D1 (de) Verfahren zur herstellung von matrizen-dna und verfahren zur proteinherstellung in einem zellfreien proteinsynthesesystem unter verwendung davon
DE602004027927D1 (de) Verwendung von labiatae-kräuterzubereitungen zur verbesserung des schaumes von getränken
ATE464320T1 (de) Ntb-a, ein oberflächenmolekül impliziert in der aktivität natürlicher killerzellen (nk)
ATE408029T1 (de) Verfahren zur herstellung und identifizierung löslicher proteindomänen
MX2023008774A (es) Composicion de vacuna para romper la autotolerancia.
ATE445009T1 (de) Signalpeptid zur herstellung eines polypeptids
DE60334316D1 (de) Frpb proteinmutante und verfahren zur erneuten faltung
ATE384790T1 (de) Uroplakin-ii-promotor aus schwein und verfahren zur herstellung nützlicher proteine unter verwendung des promotors
ATE451457T1 (de) Verfahren zur dipeptidherstellung
DE60040789D1 (de) Verfahren zur aufreinigung heterologer proteine

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1573058

Country of ref document: EP